Bay Area's First New Public Company of 2016 is OncoCyte
An East Bay molecular diagnostics company, spinning out of a longtime stem cell company, will be the Bay Area's first new public company of 2016.
But if you've never heard of OncoCyte Corp.'s plans to go public Monday, you're excused. The Alameda company shunned the traditional initial public offering pathway for a less-known route designed to give OncoCyte access to public markets.
But if you've never heard of OncoCyte Corp.'s plans to go public Monday, you're excused. The Alameda company shunned the traditional initial public offering pathway for a less-known route designed to give OncoCyte access to public markets.